These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36422242)

  • 21. Characterization of Thermotolerant Chitinases Encoded by a Brevibacillus laterosporus Strain Isolated from a Suburban Wetland.
    Liu P; Cheng D; Miao L
    Genes (Basel); 2015 Dec; 6(4):1268-82. PubMed ID: 26690223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purification, structural elucidation and bioactivity of tryptophan containing diketopiperazines, from Comamonas testosteroni associated with a rhabditid entomopathogenic nematode against major human-pathogenic bacteria.
    Kumar SN; Mohandas C; Nambisan B
    Peptides; 2014 Mar; 53():48-58. PubMed ID: 24120705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Purification and properties of an antimicrobial substance from marine Brevibacillus laterosporus Lh-1].
    Ren ZZ; Zheng Y; Sun M; Liu JZ; Wang YJ
    Wei Sheng Wu Xue Bao; 2007 Dec; 47(6):997-1001. PubMed ID: 18271253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential fate of metabolism of a disperse dye by microorganisms Galactomyces geotrichum and Brevibacillus laterosporus and their consortium GG-BL.
    Waghmode TR; Kurade MB; Kagalkar AN; Govindwar SP
    J Environ Sci (China); 2012; 24(7):1295-304. PubMed ID: 23513451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biodegradation and detoxification of textile dye Disperse Red 54 by Brevibacillus laterosporus and determination of its metabolic fate.
    Kurade MB; Waghmode TR; Khandare RV; Jeon BH; Govindwar SP
    J Biosci Bioeng; 2016 Apr; 121(4):442-9. PubMed ID: 26428603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lethal and sub-lethal activity of Brevibacillus laterosporus on the mosquito Aedes albopictus and side effects on non-target water-dwelling invertebrates.
    Bedini S; Conti B; Hamze R; Muniz ER; Fernandes ÉKK; Ruiu L
    J Invertebr Pathol; 2021 Sep; 184():107645. PubMed ID: 34245776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Full genome sequence of Brevibacillus laterosporus strain B9, a biological control strain isolated from Zhejiang, China.
    Li G; Xu J; Wu L; Ren D; Ye W; Dong G; Zhu L; Zeng D; Guo L
    J Biotechnol; 2015 Aug; 207():77-8. PubMed ID: 26022423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrastructural and pathogenicity of Brevibacillus laterosporus against sinantropic muscoid dipterans.
    de Andrade Pereira L; de Carvalho Queiroz MM; Faria SC; Zahner V
    Microsc Res Tech; 2022 Jan; 85(1):149-155. PubMed ID: 34331401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation and partial characterization of bacteria (Pseudoalteromonas sp.) with potential antibacterial activity from a marine costal environment from New Caledonia.
    Dufourcq R; Chalkiadakis E; Fauchon M; Deslandes E; Kerjean V; Chanteau S; Petit E; Guezennec J; Dupont-Rouzeyrol M
    Lett Appl Microbiol; 2014 Feb; 58(2):102-8. PubMed ID: 24106876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid polymerase chain reaction assays for Brevibacillus laterosporus detection.
    Marche MG; Mura ME; Ruiu L
    J Basic Microbiol; 2019 Aug; 59(8):853-857. PubMed ID: 31250936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation, structure elucidation and anticancer activity from Brevibacillus brevis EGS 9 that combats Multi Drug Resistant actinobacteria.
    Arumugam T; Senthil Kumar P; Hemavathy RV; Swetha V; Karishma Sri R
    Microb Pathog; 2018 Feb; 115():146-153. PubMed ID: 29278781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclo(D-Tyr-D-Phe): a new antibacterial, anticancer, and antioxidant cyclic dipeptide from Bacillus sp. N strain associated with a rhabditid entomopathogenic nematode.
    Nishanth Kumar S; Dileep C; Mohandas C; Nambisan B; Ca J
    J Pept Sci; 2014 Mar; 20(3):173-85. PubMed ID: 24353056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of active lead molecules from Lissocarinus orbicularis with potential antimicrobial resistance inhibition properties.
    Harikrishnan S; Parivallal M; S Alsalhi M; Sudarshan S; Jayaraman N; Devanesan S; Rajasekar A; Jayalakshmi S
    J Infect Public Health; 2021 Dec; 14(12):1903-1910. PubMed ID: 34750087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptome Analysis Reveals the Algicidal Mechanism of
    Zhang Y; Li J; Hu Z; Chen D; Li F; Huang X; Li C
    Toxins (Basel); 2022 Jul; 14(7):. PubMed ID: 35878230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological Activity, Apoptotic Induction and Cell Cycle Arrest of New Hydrazonoyl Halides Derivatives.
    Mohamed MF; Hassaneen HM; Elzayat EM; El-Hallouty SM; El-Manawaty M; Saleh FM; Mohamed Y; El-Zohiry D; Fahmy G; Abdelaal N; Hassanin N; Hossam N
    Anticancer Agents Med Chem; 2019; 19(9):1141-1149. PubMed ID: 30843494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An extracellular protease from Brevibacillus laterosporus G4 without parasporal crystals can serve as a pathogenic factor in infection of nematodes.
    Huang X; Tian B; Niu Q; Yang J; Zhang L; Zhang K
    Res Microbiol; 2005; 156(5-6):719-27. PubMed ID: 15950127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bystander Phage Therapy: Inducing Host-Associated Bacteria to Produce Antimicrobial Toxins against the Pathogen Using Phages.
    Brady TS; Fajardo CP; Merrill BD; Hilton JA; Graves KA; Eggett DL; Hope S
    Antibiotics (Basel); 2018 Dec; 7(4):. PubMed ID: 30518109
    [No Abstract]   [Full Text] [Related]  

  • 38. Identification of a Novel
    Barbieri G; Ferrari C; Mamberti S; Gabrieli P; Castelli M; Sassera D; Ursino E; Scoffone VC; Radaelli G; Clementi E; Sacchi L; Ferrari E; Gasperi G; Albertini AM
    Front Microbiol; 2021; 12():624014. PubMed ID: 33679643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioactivity assessment of the Saudi Arabian Marine Streptomyces sp. Al-Dhabi-90, metabolic profiling and its in vitro inhibitory property against multidrug resistant and extended-spectrum beta-lactamase clinical bacterial pathogens.
    Al-Dhabi NA; Mohammed Ghilan AK; Esmail GA; Valan Arasu M; Duraipandiyan V; Ponmurugan K
    J Infect Public Health; 2019; 12(4):549-556. PubMed ID: 30755364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular characterization of Brevibacillus laterosporus and its potential use in biological control.
    de Oliveira EJ; Rabinovitch L; Monnerat RG; Passos LK; Zahner V
    Appl Environ Microbiol; 2004 Nov; 70(11):6657-64. PubMed ID: 15528531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.